Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Dudley

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
International Journal of Andrology|October 26, 2010
Steady-state pharmacokinetics of oral testosterone undecanoate with concomitant inhibition of 5α-reductase by finasterideM Y Roth, R E Dudley, L Hull, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1995
Pharmacokinetics, bioefficacy, and safety of sublingual testosterone cyclodextrin in hypogonadal men: comparison to testosterone enanthate--a clinical research center studyB Salehian, C Wang, G Alexander, et al.
Pharmacology|January 1, 1992
Plasma concentrations and pharmacokinetics of phenylalanine in rats and mice administered aspartameJ J Hjelle, R E Dudley, M P Marietta, et al.
The Journal of Clinical Endocrinology and Metabolism|March 17, 2000
Pharmacokinetics of transdermal testosterone gel in hypogonadal men: application of gel at one site versus four sites: a General Clinical Research Center StudyC Wang, N Berman, J A Longstreth, et al.
The Journal of Clinical Endocrinology and Metabolism|August 26, 1998
Comparative pharmacokinetics of three doses of percutaneous dihydrotestosterone gel in healthy elderly men--a clinical research center studyC Wang, A Iranmanesh, N Berman, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1996
Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men--a clinical research center studyC Wang, D R Eyre, R Clark, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
International Journal of Andrology|October 26, 2010
Steady-state pharmacokinetics of oral testosterone undecanoate with concomitant inhibition of 5α-reductase by finasterideM Y Roth, R E Dudley, L Hull, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1995
Pharmacokinetics, bioefficacy, and safety of sublingual testosterone cyclodextrin in hypogonadal men: comparison to testosterone enanthate--a clinical research center studyB Salehian, C Wang, G Alexander, et al.
Pharmacology|January 1, 1992
Plasma concentrations and pharmacokinetics of phenylalanine in rats and mice administered aspartameJ J Hjelle, R E Dudley, M P Marietta, et al.
The Journal of Clinical Endocrinology and Metabolism|March 17, 2000
Pharmacokinetics of transdermal testosterone gel in hypogonadal men: application of gel at one site versus four sites: a General Clinical Research Center StudyC Wang, N Berman, J A Longstreth, et al.
The Journal of Clinical Endocrinology and Metabolism|August 26, 1998
Comparative pharmacokinetics of three doses of percutaneous dihydrotestosterone gel in healthy elderly men--a clinical research center studyC Wang, A Iranmanesh, N Berman, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1996
Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men--a clinical research center studyC Wang, D R Eyre, R Clark, et al.
Pageof 2